AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 13 filers reported holding AMRYT PHARMA PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $657,354 | -62.1% | 45,086 | -81.0% | 0.00% | -100.0% |
| Q4 2022 | $1,734,000 | +5.5% | 237,608 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,644,000 | -1.0% | 237,608 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,661,000 | -15.4% | 237,608 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,963,000 | -23.5% | 237,608 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,566,000 | -22.1% | 237,608 | -12.8% | 0.00% | 0.0% |
| Q3 2021 | $3,296,000 | -0.3% | 272,608 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $3,307,000 | -12.9% | 272,608 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $3,797,000 | -1.6% | 272,608 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $3,860,000 | -56.2% | 272,608 | -62.0% | 0.00% | -75.0% |
| Q3 2020 | $8,817,000 | – | 716,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,912,000 | 26.04% |
| Stonepine Capital Management, LLC | 6,298,348 | $44,025,000 | 20.48% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,655,000 | 7.87% |
| Aquilo Capital Management, LLC | 1,866,652 | $13,048,000 | 4.45% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,144,000 | 2.04% |
| Global Frontier Investments LLC | 435,000 | $3,040,000 | 1.42% |
| Rubric Capital Management LP | 3,600,000 | $25,164,000 | 1.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $44,272,000 | 1.01% |
| Telemetry Investments, L.L.C. | 121,670 | $850,000 | 1.01% |
| Clearline Capital LP | 631,942 | $4,417,000 | 0.57% |